文献速递肝病消化道肿瘤与早癌

基底外侧CD147通过E-钙黏蛋白泛素化降解诱导肝细胞极性丧失促进肝细胞癌进展

Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress.
PubMed 文献 · Hepatology · 2018-03-23

研究在肝组织和HepG2细胞中鉴定CD147呈基底外侧极性分布,其通过竞争结合整合素β1激活Src-Hakai通路致E-钙黏蛋白泛素化降解,诱导肝细胞去极化。人肝组织中CD147极性率从肝硬化71.4%降至肝细胞癌10.4%,且与Child-Pugh评分负相关、与分化分级正相关,极性分布者总生存更优。

要点

  • CD147在肝细胞膜呈基底外侧极性分布,过表达诱导肝细胞极性丧失。
  • CD147通过整合素α5β1-Src-Hakai轴促进E-钙黏蛋白泛素化及溶酶体降解。
  • CD147极性率肝硬化71.4% vs 肝细胞癌10.4%,极性分布者总生存更优(P=0.021)。

核心结论

  • 异位基底外侧膜CD147极性分布通过激活CD147-整合素α5β1-E-钙黏蛋白泛素化-分区缺陷蛋白3减少及β-连环蛋白转位信号级联促进肝细胞去极化,补充了肝癌发生的分子通路。

研究设计与样本

  • 研究在肝组织与HepG2细胞中检测CD147极性分布,并分析人肝组织样本中CD147极性率与临床指标的关系。

主要发现

  • CD147不仅促进转化生长因子-β1介导的肝细胞极性丧失,还直接诱导E-钙黏蛋白内吞和下调。
  • CD147过表达诱导Src激活并招募泛素连接酶Hakai,导致E-钙黏蛋白泛素化及溶酶体降解,进而减少分区缺陷蛋白3表达和β-连环蛋白核转位。
  • 该信号由CD147与整合素β1竞争性结合启动,中断纤连蛋白Arg-Gly-Asp基序与整合素β1的相互作用。
  • 靶向整合素α5和β1的特异性抗体逆转了CD147过表达引起的E-钙黏蛋白和分区缺陷蛋白3水平下降。
  • 人肝组织中CD147极性率从肝硬化71.4%显著降至肝细胞癌10.4%;CD147极性定位与肝硬化Child-Pugh评分负相关(r=-0.6092,P<0.0001),与肝细胞癌分化分级正相关(r=0.2060,P=0.004)。

关键数值与推荐

  • 肝细胞癌患者中CD147极性定位者总生存显著优于非极性者(P=0.021)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Hepatocytes are epithelial cells with highly specialized polarity. The disorder and loss of hepatocyte polarity leads to a weakness of cell adhesion and connection, the induction of epithelial-mesenchymal transition, and eventually the occurrence of hepatocellular carcinoma (HCC). Cluster of differentiation 147 (CD147), a tumor-related glycoprotein, promotes epithelial-mesenchymal transition and the invasion of HCC. However, the function of CD147 in hepatocyte depolarization is unknown. Here we identified that CD147 was basolaterally polarized in hepatocyte membrane of liver tissues and HepG2 cells. CD147 not only promoted transforming growth factor-β1-mediated hepatocyte polarity loss but also directly induced endocytosis and down-regulation of E-cadherin which contributed to hepatocyte depolarization. Overexpression of CD147 induced Src activation and subsequently recruited ubiquitin ligase Hakai for E-cadherin ubiquitination and lysosomal degradation, leading to decreases of partitioning defective 3 expression and β-catenin nuclear translocation. This signal transduction was initiated by competitive binding of CD147 with integrin β1 that interrupted the interaction between the Arg-Gly-Asp motif of fibronectin and integrin β1. The specific antibodies targeting integrin α5 and β1 reversed the decrease of E-cadherin and partitioning defective 3 levels induced by CD147 overexpression. In human liver tissues, CD147 polarity rates significantly declined from liver cirrhosis (71.4%) to HCC (10.4%). CD147-polarized localization negatively correlated with Child-Pugh scores in human liver cirrhosis (r = -0.6092, P < 0.0001) and positively correlated with differentiation grades in HCC (r = 0.2060, P = 0.004). HCC patients with CD147-polarized localization had significantly better overall survival than patients with CD147 nonpolarity (P = 0.021). CONCLUSION: The ectopic CD147-polarized distribution on basolateral membrane promotes hepatocyte depolarization by activation of the CD147-integrin α5β1-E-cadherin ubiquitination-partitioning defective 3 decrease and β-catenin translocation signaling cascade, replenishing a molecular pathway in hepatic carcinogenesis. (Hepatology 2018;68:317-332).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lu M, Wu J, Hao ZW, et al. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress. Hepatology. 2018. PMID: 29356040. doi:10.1002/hep.29798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。